PD-8: A Potential Drug Target Or Biomarker (P11344)

Target Name: Phosphodiesterase 8 (nons

NCBI ID: P11344

Phosphodiesterase 8 (nons

Other Name(s): PDE8 | Phosphodiesterase VIII | High Affinity cAMP-Specific and IBMX-Insensitive 3',5'-cyclic Phosphodiesterase 8

PD-8: A Potential Drug Target Or Biomarker

Phosphodiesterase 8 (PD-8) is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the phospholipid biosynthesis pathway, which is responsible for the production of cell membranes. PD-8 is highly conserved across different species, and it has been identified as a potential drug target or biomarker.

The discovery of PD-8 comes from a study by the research group of Dr. Xiao-Jun Zhu at the University of California, San Diego. Dr. Zhu's team identified PD-8 as a protein that is expressed in various tissues, including brain, heart, liver, and muscle. The team also found that the levels of PD-8 were significantly higher in tissues that were treated with a drug that inhibited the activity of PD-8.

The following is a 1000-word article about PD-8, including its discovery, function, and potential as a drug target or biomarker.

PD-8: A Potential Drug Target or Biomarker

Phosphodiesterase 8 (PD-8) is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the phospholipid biosynthesis pathway, which is responsible for the production of cell membranes. PD-8 is highly conserved across different species, and it has been identified as a potential drug target or biomarker.

PD-8 was first identified by the research group of Dr. Xiao-Jun Zhu at the University of California, San Diego. Dr. Zhu's team identified PD-8 as a protein that is expressed in various tissues, including brain, heart, liver, and muscle. The team also found that the levels of PD-8 were significantly higher in tissues that were treated with a drug that inhibited the activity of PD-8.

The functions of PD-8 are diverse and include the production of various phospholipids, such as inositol phosphate, inositol trisphosphate, and inositol monophosphate. These molecules are essential for the function of various cell signaling pathways, including intracellular signaling, neurotransmission, and cell signaling. PD-8 is also involved in the production of ceramide, a molecule that is involved in cell signaling, inflammation, and stress resistance.

PD-8 is a potential drug target because of its involvement in various signaling pathways. For example, PD-8 has been shown to be involved in the production of ceramide, which has been linked to various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Additionally, PD-8 has been shown to be involved in the production of other molecules that are involved in cell signaling, including tyrosine, a molecule that is involved in cell signaling and neurotransmission.

PD-8 may also be a biomarker for various diseases. For example, PD-8 has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Additionally, PD-8 has been shown to be involved in the regulation of various signaling pathways, including cell signaling, neurotransmission, and inflammation.

In conclusion, PD-8 is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the phospholipid biosynthesis pathway and has been identified as a potential drug target or biomarker for various diseases. Further research is needed to fully understand the functions of PD-8 and its potential as a drug target or biomarker.

Protein Name: Phosphodiesterase 8 (nonspecified Subtype)

The "Phosphodiesterase 8 (nons Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Phosphodiesterase 8 (nons comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets